Pfizer - Options Analysis

Posted on 03/19/2013 by Evelyn Greenberg

Share on StockTwits

NEW YORK (AVAFIN) -- Pfizer options set a new 90-day record for the number of call contracts that exchanged hands between the buyers and the sellers. Aggregate volume of puts was 5,753 and calls was 23,719 equating to a 0.24 put/call ratio.

Investors use options to manage risk and to speculate on price changes. Options can provide significant leverage if the stock moves in the right direction but aslo end up worthless if it doesn't.

Austerity measures in Europe are likely to put pricing pressure on an important market for Pfizer. Additionaly, We estimate that Lipitor generates gross margins in excess of 90%. Even if the firm manages to replace most of the revenue it will lose from generic competition around the end of the decade, its newer products will most likely bring less profit per dollar than Lipitor has.

Shares of Pfizer slipped $0.05 (0.18%) to $27.99. The last trading session witnessed a low of $27.90 and high of $28.23 during the day. The current trading volume of 26M is less than average volume of 32M shares. PFE is trading above the 50 day moving average and higher than the 200 day moving average. The stock's 52 week low is $21.40 and 52 week high is $28.38. Performance indicators show that the stock has gained 3.62% within the last month.

AVAFIN Options Pro for only $20/Month:

Sign in / New to Options Pro? Sign up (More Info)
Password Reset: Email will be sent with instructions how to activate your new password.

:: Market Movers ::

:: Technical Alerts ::

:: Candle Stick Alerts ::

:: Chart Patterns ::

:: Options Advisory Center ::

:: Block Trades Review ::

:: Trade Flow Analysis ::